PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development.

Abstract

Unfolded protein responses (UPR), consisting of three major transducers PERK, IRE1, and ATF6, occur in the midst of a variety of intracellular and extracellular challenges that perturb protein folding in the endoplasmic reticulum (ER). ER stress occurs and is thought to be a contributing factor to a number of human diseases, including cancer, neurodegenerative disorders, and various metabolic syndromes. In the context of neoplastic growth, oncogenic stress resulting from dysregulation of oncogenes such as c-Myc, Braf(V600E) , and HRAS(G12V) trigger the UPR as an adaptive strategy for cancer cell survival. PERK is an ER resident type I protein kinase harboring both pro-apoptotic and pro-survival capabilities. PERK, as a coordinator through its downstream substrates, reprograms cancer gene expression to facilitate survival in response to oncogenes and microenvironmental challenges, such as hypoxia, angiogenesis, and metastasis. Herein, we discuss how PERK kinase engages in tumor initiation, transformation, adaption microenvironmental stress, chemoresistance and potential opportunities, and potential opportunities for PERK targeted therapy. J. Cell. Physiol. 231: 2088-2096, 2016. © 2016 Wiley Periodicals, Inc.

• Authors: Yiwen Bu, J Alan Diehl
• Journal: Journal of cellular physiology (J Cell Physiol) Vol. 231 Issue 10 Pg. 2088-96 (10 2016) ISSN: 1097-4652 [Electronic] United States
• PMID: 26864318 (Publication Type: Journal Article, Review, Research Support, N.I.H., Extramural)
• Copyright: © 2016 Wiley Periodicals, Inc.

Chemical References

• PERK kinase
• eIF-2 Kinase

Topics

• Animals
• Carcinogenesis (metabolism)
• Cell Survival (physiology)
• Cell Transformation, Neoplastic (metabolism)
• Endoplasmic Reticulum Stress (physiology)
• Humans
• Signal Transduction (physiology)
• eIF-2 Kinase (metabolism)